Krečak, I., Bačić, J. A., Šimunić, N., Bušac, V., Pivac, Lj., Čubrić, E. ... Lucijanić, M. (2024). No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study. Heliyon, 10. (12). doi: 10.1016/j.heliyon.2024.e32827
Krečak, Ivan, et al. "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study." Heliyon, vol. 10, br. 12, 2024. https://doi.org/10.1016/j.heliyon.2024.e32827
Krečak, Ivan, Josipa Antonija Bačić, Nevena Šimunić, Vesna Bušac, Ljerka Pivac, Eva Čubrić, Marko Skelin i Marko Lucijanić. "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study." Heliyon 10, br. 12 (2024). https://doi.org/10.1016/j.heliyon.2024.e32827
Krečak, I., et al. (2024) 'No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study', Heliyon, 10(12). doi: 10.1016/j.heliyon.2024.e32827
Krečak I, Bačić JA, Šimunić N, Bušac V, Pivac Lj, Čubrić E, i sur.. No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study. Heliyon [Internet]. 11.06.2024. [pristupljeno 24.12.2024.];10(12). doi: 10.1016/j.heliyon.2024.e32827
I. Krečak, et al., "No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study", Heliyon, vol. 10, br. 12, Lipanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:314923. [Citirano: 24.12.2024.]